These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17210516)

  • 1. Telomere length and telomerase expression in atypical adenomatous hyperplasia and small bronchioloalveolar carcinoma of the lung.
    Kawai T; Hiroi S; Nakanishi K; Meeker AK
    Am J Clin Pathol; 2007 Feb; 127(2):254-62. PubMed ID: 17210516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomere shortening and telomerase reverse transcriptase expression in preinvasive bronchial lesions.
    Lantuejoul S; Soria JC; Morat L; Lorimier P; Moro-Sibilot D; Sabatier L; Brambilla C; Brambilla E
    Clin Cancer Res; 2005 Mar; 11(5):2074-82. PubMed ID: 15756034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomere length, telomerase activity, and expressions of human telomerase mRNA component (hTERC) and human telomerase reverse transcriptase (hTERT) mRNA in pulmonary neuroendocrine tumors.
    Nishio Y; Nakanishi K; Ozeki Y; Jiang SX; Kameya T; Hebisawa A; Mukai M; Travis WD; Franks TJ; Kawai T
    Jpn J Clin Oncol; 2007 Jan; 37(1):16-22. PubMed ID: 17060405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of mRNAs for telomeric repeat binding factor (TRF)-1 and TRF2 in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
    Nakanishi K; Kawai T; Kumaki F; Hiroi S; Mukai M; Ikeda E; Koering CE; Gilson E
    Clin Cancer Res; 2003 Mar; 9(3):1105-11. PubMed ID: 12631614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma.
    Kerr KM; MacKenzie SJ; Ramasami S; Murray GI; Fyfe N; Chapman AD; Nicolson MC; King G
    J Pathol; 2004 Jun; 203(2):638-44. PubMed ID: 15141378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survivin expression in atypical adenomatous hyperplasia of the lung.
    Nakanishi K; Kawai T; Kumaki F; Hiroi S; Mukai M; Ikeda E
    Am J Clin Pathol; 2003 Nov; 120(5):712-9. PubMed ID: 14608897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is high-grade adenomatous hyperplasia an early bronchioloalveolar adenocarcinoma?
    Ullmann R; Bongiovanni M; Halbwedl I; Fraire AE; Cagle PT; Mori M; Papotti M; Popper HH
    J Pathol; 2003 Nov; 201(3):371-6. PubMed ID: 14595748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of human telomerase RNA component and telomerase reverse transcriptase mRNA in atypical adenomatous hyperplasia of the lung.
    Nakanishi K; Kawai T; Kumaki F; Hirot S; Mukai M; Ikeda E
    Hum Pathol; 2002 Jul; 33(7):697-702. PubMed ID: 12196920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of telomerase activity in lung carcinoids is dependent on human telomerase reverse transcriptase transcription and alternative splicing and is associated with long telomeres.
    Zaffaroni N; Villa R; Pastorino U; Cirincione R; Incarbone M; Alloisio M; Curto M; Pilotti S; Daidone MG
    Clin Cancer Res; 2005 Apr; 11(8):2832-9. PubMed ID: 15837730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung adenocarcinoma with bronchioloalveolar carcinoma component is frequently associated with foci of high-grade atypical adenomatous hyperplasia.
    Koga T; Hashimoto S; Sugio K; Yonemitsu Y; Nakashima Y; Yoshino I; Matsuo Y; Mojtahedzadeh S; Sugimachi K; Sueishi K
    Am J Clin Pathol; 2002 Mar; 117(3):464-70. PubMed ID: 11888087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomere maintenance and DNA damage responses during lung carcinogenesis.
    Lantuejoul S; Raynaud C; Salameire D; Gazzeri S; Moro-Sibilot D; Soria JC; Brambilla C; Brambilla E
    Clin Cancer Res; 2010 Jun; 16(11):2979-88. PubMed ID: 20404006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung.
    Seki N; Takasu T; Mandai K; Nakata M; Saeki H; Heike Y; Takata I; Segawa Y; Hanafusa T; Eguchi K
    Clin Cancer Res; 2002 Oct; 8(10):3046-53. PubMed ID: 12374671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease of telomeres and increase of interstitial telomeric sites in chromosomes of short-term cultured gastric carcinoma cells detected by fluorescence in situ hybridization.
    Kashima K; Nanashima A; Yasutake T; Sawai T; Tsuji T; Hidaka S; Akama F; Miyashita K; Tagawa Y; Nagayasu T
    Anticancer Res; 2006; 26(4B):2849-55. PubMed ID: 16886604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonality of atypical adenomatous hyperplasia of the lung.
    Niho S; Yokose T; Suzuki K; Kodama T; Nishiwaki Y; Mukai K
    Am J Pathol; 1999 Jan; 154(1):249-54. PubMed ID: 9916939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of hTERT mRNA in a mortal liver cell line during S phase without detectable telomerase activity.
    Nagao K; Ohyashiki JH; Ohyashiki K; Tabata K; Takai K; Kameyama K; Kitano S; Kawano K; Hibi N; Kanamaru T; Hisatomi H
    Int J Mol Med; 2005 Apr; 15(4):683-8. PubMed ID: 15754032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal growth of atypical adenomatous hyperplasia of the lung: cytofluorometric analysis of nuclear DNA content.
    Nakayama H; Noguchi M; Tsuchiya R; Kodama T; Shimosato Y
    Mod Pathol; 1990 May; 3(3):314-20. PubMed ID: 2362938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The level of telomere dysfunction determines the efficacy of telomerase-based therapeutics in a lung cancer cell line.
    Pantic M; Zimmermann S; Waller CF; Martens UM
    Int J Oncol; 2005 May; 26(5):1227-32. PubMed ID: 15809713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
    Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
    Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase activity and hTERT protein expression in meningiomas: an analysis in vivo versus in vitro.
    Maes L; Kalala JP; Cornelissen R; de Ridder L
    Anticancer Res; 2006; 26(3B):2295-300. PubMed ID: 16821605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung.
    Morandi L; Asioli S; Cavazza A; Pession A; Damiani S
    Lung Cancer; 2007 Apr; 56(1):35-42. PubMed ID: 17241687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.